Xin Lang Cai Jing·2025-09-19 08:12Core Points - The company, Sailong Pharmaceutical Group Co., Ltd., held its 15th meeting of the 4th Board of Directors on September 19, 2025, to review and approve a proposal for credit facilities from a bank [1] - The company plans to apply for a comprehensive credit limit of 10 million yuan from Industrial Bank Zhuhai Branch for a duration of one year, aimed at supporting operational and business development needs [1] - The actual financing amount will depend on operational requirements and will be finalized upon contract signing, with the credit limit being reusable [1] - The Board of Directors has authorized the management to make decisions and sign documents within the approved limit, with the company bearing the responsibility [1] - This credit application falls within the scope of the Board's review and does not require shareholder meeting approval, with the credit period starting from the date of Board approval [1]